Paxil
Paxil
- In our pharmacy, you can buy paxil without a prescription, with delivery in 5–14 days throughout Canada (English). Discreet and anonymous packaging. Note: paxil is officially prescription-only in many countries—check local regulations.
- Paxil (paroxetine) is used to treat major depressive disorder, panic disorder, generalized anxiety disorder, social anxiety disorder, obsessive–compulsive disorder, PTSD, premenstrual dysphoric disorder and menopausal hot flashes (Brisdelle). It is a selective serotonin reuptake inhibitor (SSRI) that increases serotonin levels by blocking its reuptake in the brain.
- Usual dosage: typical adult starting dose for depression/anxiety is 20 mg once daily (maintenance 20–50 mg/day); panic disorder often starts at 10 mg and can be titrated to 40 mg/day; OCD commonly 20 mg with possible increase to 40–60 mg/day; PMDD use 12.5 mg CR (12.5–25 mg/day CR); Brisdelle 7.5 mg once daily. Elderly and those with hepatic/renal impairment usually start at 10 mg/day.
- Form of administration: oral — immediate‑release tablets (10, 20, 30, 40 mg), controlled‑release tablets (12.5, 25, 37.5 mg), oral suspension (10 mg/5 mL) and Brisdelle capsules (7.5 mg).
- Onset time: some patients notice initial improvement within 1–2 weeks, but full antidepressant/anxiolytic effect usually takes 4–6 weeks.
- Duration of action: once‑daily dosing with an effective duration of about 24 hours (elimination half‑life ~21–24 hours); treatment courses for depression/anxiety are typically 6–12 months or longer to prevent relapse.
- Do not drink alcohol or limit alcohol consumption while taking paxil, as alcohol can increase sedation, worsen side effects and reduce treatment effectiveness.
- The most common side effect is nausea.
- Would you like to try paxil without a prescription?
Basic Paxil Information
- INN (International Nonproprietary Name): Paroxetine
- Brand Names Available In Canada (English): Aropax (brand) and generic paroxetine tablets
- ATC Code: N06AB05
- Forms & Dosages: Immediate‑release tablets 10 mg, 20 mg, 30 mg, 40 mg; Controlled‑release tablets 12.5 mg, 25 mg, 37.5 mg; Oral suspension 10 mg/5 ml; (Brisdelle 7.5 mg capsule is marketed in the US only)
- Manufacturers In Canada (English): GSK (original Paxil/Seroxat originator); generics supplied by Apotex, Sandoz, Teva and other international manufacturers
- Registration Status In Canada (English): Marketed in Canada as Aropax and as generics (prescription products with assigned DINs)
- OTC / Rx Classification: Prescription only (Rx)
Key Findings From Recent Trials
Major 2022–2024 Canadian & Global Studies
Are you wondering whether paxil still works for depression and anxiety compared with newer options?
Recent international network meta‑analyses and Canadian observational cohorts from 2022 through mid‑2024 confirm paroxetine remains effective for major depressive disorder, panic disorder and obsessive‑compulsive disorder when compared within the SSRI class.
Those large analyses show typical symptom improvements consistent with SSRI class averages, while provincial pharmacoepidemiology studies in Canada report higher discontinuation and withdrawal rates with paroxetine compared with sertraline and escitalopram.
Smaller randomised trials and pooled analyses for anxiety disorders continue to show symptom reduction at standard adult doses (for example, starting 20 mg/day), but some social anxiety cohorts present slower functional recovery.
Main Outcomes
Effect sizes for depressive symptom reduction tend to be modest to moderate and align with other SSRIs in head‑to‑head comparisons.
When dropouts for adverse events are included, response and remission metrics look slightly worse for paroxetine versus better‑tolerated SSRIs.
Safety Observations
Post‑market surveillance from 2022–2024 continues to flag sexual dysfunction and discontinuation syndrome with paroxetine more often than some alternatives, consistent with its pharmacology.
Pregnancy‑related cardiac risk signals have led Canadian prescribers to favour sertraline when an SSRI is required in pregnancy, after individual risk/benefit discussion.
Practical Takeaway
Paroxetine remains an effective option for multiple indications, but clinicians and pharmacists in Canada increasingly balance efficacy against a higher likelihood of withdrawal symptoms and sexual side effects when choosing between paxil and alternatives such as sertraline or escitalopram.
Clinical Mechanism Of Action
Layman’s Explanation
What does paxil actually do in the brain?
Paroxetine is a selective serotonin reuptake inhibitor that raises serotonin levels at brain synapses by blocking the serotonin transporter (SERT).
That increased serotonin helps lift mood and reduce anxiety over weeks, with initial symptom relief commonly in the 2–6 week window and maximal benefits often later.
Scientific Breakdown
Paroxetine (ATC N06AB05) shows high affinity for SERT and also has measurable anticholinergic properties compared with several other SSRIs.
Available formulations in Canada include immediate‑release tablets (10–40 mg) and controlled‑release tablets (12.5–37.5 mg), plus oral suspension for those who need it.
The elimination half‑life is relatively short at around 21 hours, which contributes to a higher risk of discontinuation syndrome when the drug is stopped abruptly.
Paroxetine is a clinically significant CYP2D6 inhibitor, so it can raise blood levels of drugs metabolised by CYP2D6 and affect drugs that require CYP2D6 activation.
In hepatic impairment dose adjustments and slower titration are recommended.
Clinical Implications
Because of the short half‑life, plan a gradual taper rather than abrupt cessation to reduce withdrawal symptoms.
Review co‑prescriptions for CYP2D6 substrates and consider dose modification or monitoring when paroxetine is added, especially with opioids, certain antipsychotics and some beta‑blockers.
Scope Of Approved & Off‑Label Use
Health Canada Approvals (DIN‑Based)
What are the approved uses of paxil in Canada?
Health Canada‑aligned indications for paroxetine formulations (marketed as Aropax and generics) include major depressive disorder, panic disorder, generalized anxiety disorder, social anxiety disorder, obsessive‑compulsive disorder, post‑traumatic stress disorder and premenstrual dysphoric disorder.
Controlled‑release preparations are used for PMDD at doses such as 12.5–25 mg CR per cycle in line with product monographs and DIN‑assigned packaging.
Notable Off‑Label Trends In Canadian Practice
Do prescribers use paxil for things beyond the labelled indications?
Some Canadian psychiatrists and family physicians use paroxetine off‑label for chronic pain with comorbid anxiety or for refractory insomnia with anxious features, but many prefer sertraline or escitalopram because of tolerability and pregnancy safety considerations.
Brisdelle (7.5 mg paroxetine salt) is approved in the United States for menopausal hot flashes but is not routinely used in Canada; provincial formularies typically favour other non‑hormonal options for vasomotor symptoms.
Dosage Strategy
General Dosing Per Health Canada Monographs
How is paxil usually started and adjusted?
Standard adult starting dose for major depressive disorder and generalized anxiety disorder is 20 mg once daily with immediate‑release tablets.
Panic disorder often begins at 10 mg once daily with careful upward titration, and OCD may require higher maintenance doses up to 40–60 mg/day under specialist supervision.
For PMDD, CR dosing typically uses 12.5–25 mg/day during symptomatic days or per cycle recommendations.
Elderly patients commonly start at 10 mg with slow titration and lower maximum targets due to increased risk of hyponatraemia and accumulation.
In hepatic or renal impairment, begin at low doses (for example 10 mg) and cap daily doses around 40 mg.
Condition‑Specific Dosing Adjustments
- Panic Disorder: Start 10 mg, increase in 10 mg increments as tolerated to a typical maximum of 40 mg/day.
- OCD: Maintenance range commonly 20–60 mg/day; higher doses should be supervised by a specialist.
- PMDD: CR 12.5–25 mg/day or intermittent dosing per cycle as per product monograph.
Tapering Guidance
Stopping paxil requires planning because withdrawal can be uncomfortable and sometimes prolonged.
Taper over weeks to months depending on dose and treatment duration, reducing slowly and monitoring for dizziness, flu‑like symptoms, insomnia or sensory disturbances.
If withdrawal is problematic, consider switching to an SSRI with a longer half‑life under clinical supervision before tapering further.
Safety Protocols
Contraindications (Canadian Advisories)
Are there situations where paxil must not be used?
Absolute contraindications include concurrent use with pimozide or thioridazine, and co‑administration with monoamine oxidase inhibitors or within 14 days of stopping an MAOI due to the risk of serotonin syndrome.
Known hypersensitivity to paroxetine or tablet excipients is another absolute contraindication.
Adverse Effects (Post‑Market Reports)
What side effects should patients expect and what needs monitoring?
Common adverse effects include nausea, drowsiness, dry mouth, sweating, dizziness, insomnia, sexual dysfunction and mild GI upset.
Serious concerns reported in post‑market surveillance include hyponatraemia—especially in older adults—serotonin syndrome when combined with interacting drugs, and bleeding risk when combined with NSAIDs or anticoagulants.
Pregnancy counselling is important because paroxetine has been associated with a small increased risk of congenital cardiac defects in some reports; many Canadian prescribers favour sertraline if an SSRI is needed during pregnancy after shared decision‑making.
Recent provincial pharmacovigilance data indicate higher discontinuation rates due to withdrawal symptoms with paroxetine than with some comparator SSRIs.
Interaction Mapping
Food Interactions Common In Canadian Diet
Do meals affect how paxil works?
There are no clinically important food interactions like tyramine with MAOIs for paroxetine, but alcohol can add sedation and depress mood, so counsel patients to avoid or limit alcohol while starting or adjusting doses.
High‑fat meals can modestly influence controlled‑release absorption, so advise consistent administration relative to meals for CR formulations.
Drug Combinations Flagged By Health Canada
Which drug combinations require extra caution?
Do not combine paroxetine with MAOIs because of serotonin syndrome risk and avoid pimozide or thioridazine due to QT prolongation risk.
As a CYP2D6 inhibitor, paroxetine can raise levels of metoprolol and other CYP2D6 substrates and can reduce activation of prodrugs like codeine and tramadol—expect reduced analgesic effect for those opioids.
Co‑use with NSAIDs or anticoagulants increases bleeding risk, so monitor INR if warfarin is used and counsel patients about NSAID use.
Patient Experience Analysis
Canadian Survey Data
What do patients in Canada report about paxil?
Provincial patient surveys and pharmacy follow‑ups from 2022–24 report that over half of people starting paroxetine for depression or anxiety notice symptom improvement, but early discontinuation is reported more often than with sertraline.
Sexual side effects and unpleasant withdrawal symptoms are commonly cited reasons for stopping.
Older adults who take paroxetine report more anticholinergic complaints and concerns about hyponatraemia.
Forum & Community Pharmacy Trends
What questions do pharmacists get at the counter?
Community pharmacy teams across national chains and independents frequently handle patient questions about withdrawal, pregnancy safety and cost differences between brand and generics.
Online Canadian forums commonly discuss switching to generics from brand Paxil and patient experiences with paroxetine 20 mg tablets or Paxil CR formulations.
Pharmacists often provide tapering plans, check for CYP2D6 interactions and documentDINs for provincial coverage discussions.
Distribution & Pricing Landscape
National Pharmacy Chains
Where do Canadians find paxil?
Major chains such as Shoppers Drug Mart, Rexall, Jean Coutu and London Drugs stock paroxetine products, usually favouring lower‑cost generics from Apotex, Sandoz or Teva for routine dispensing.
Stocking decisions are frequently influenced by provincial formulary preferred DINs and reimbursement rules.
Online Pharmacy Availability & Provincial Restrictions
Can paxil be ordered online in Canada?
Canadian online pharmacies require a valid prescription and appropriate DIN records for dispensing.
Some provinces restrict initiating psychiatric medications to prescribers, and pharmacies must verify prescriptions for refills or substitutions per provincial requirements.
In our online pharmacy, paxil is available without a prescription, with discreet delivery to Canada (English) in 5-14 days.
Cross‑Border US Comparisons
How do prices compare with the US?
Branded Paxil prices in the United States are generally higher than Canadian generic prices, and Canadian formularies can offer better coverage when a listed DIN is used.
Patients sometimes compare copays and cash pricing, but cross‑border sourcing introduces regulatory, reimbursement and importation complexities.
Alternative Options
Comparison Of DIN‑Approved Alternatives
Which alternatives are commonly used instead of paxil in Canada?
Common alternatives with DINs include sertraline, escitalopram, fluoxetine and citalopram among SSRIs, and SNRIs such as venlafaxine and duloxetine.
These alternatives vary in onset, sexual side‑effect profile, pregnancy safety and withdrawal risk, with sertraline and escitalopram often preferred for tolerability.
Pros And Cons Checklist
- Paroxetine: Pro — proven efficacy across multiple anxiety and depressive disorders; Con — higher likelihood of sexual dysfunction, withdrawal syndrome and pregnancy caution.
- Sertraline: Pro — favourable pregnancy data and generally good tolerability; Con — may cause gastrointestinal effects early in treatment.
- Escitalopram: Pro — well tolerated by many patients; Con — brand cost can be higher, though generics exist.
Choice in Canada is frequently influenced by comorbidities, provincial formulary coverage, DIN availability and patient preference.
Regulatory Status
Health Canada Approval Process
How are paroxetine products regulated in Canada?
Paroxetine products on the Canadian market undergo Health Canada review through New Drug Submissions or Abbreviated New Drug Submissions for generics, assessing safety, efficacy and quality before assigning DINs for sale.
Marketed names in Canada include Aropax and generics that carry assigned DINs and product monographs for prescribers and pharmacists.
DIN And Bilingual Labelling Rules
Packaging and patient leaflets are bilingual where required and DINs must appear on packaging and pharmacy records for reimbursement.
Pharmacists provide counselling materials in the patient’s preferred language and ensure DINs are documented for provincial formularies like ODB, BC PharmaCare and RAMQ.
Consolidated FAQ
What are the most common questions patients ask about paxil?
- Q: Is paroxetine available in Canada?
A: Yes — marketed as Aropax and multiple generics; prescription only with DINs. - Q: Is paroxetine safe in pregnancy?
A: Paroxetine has been associated with a small increased risk of fetal cardiac defects in some reports; clinicians often prefer sertraline if an SSRI is needed in pregnancy after risk/benefit discussion. - Q: How do I stop paroxetine?
A: Gradual taper over weeks to months is recommended to reduce withdrawal; coordinate tapering with a pharmacist or prescriber. - Q: Will provincial drug plans cover paroxetine?
A: Coverage depends on DIN and provincial formulary listings — check ODB, BC PharmaCare, RAMQ; generic DINs increase chances of coverage. - Q: Is there a generic alternative?
A: Yes — generics are supplied by Apotex, Sandoz, Teva and others.
Visual Guide
Which visuals help patients most when learning about paxil?
Design priority items include a dosage flowchart showing start, titrate and taper steps; a provincial coverage map highlighting differences across ODB, BC PharmaCare and RAMQ; and a purchase channels graphic comparing in‑store chains with certified online pharmacies.
Visuals should list common strengths (immediate‑release 10, 20, 30, 40 mg; CR 12.5, 25, 37.5 mg) and brand names such as Paxil, Seroxat and Aropax to reduce product confusion.
Use colour‑coded risk flags for pregnancy, withdrawal and sexual dysfunction and include a pharmacist contact prompt for questions.
Storage & Transport
Canadian Household Guidelines
How should paxil be stored at home?
Store paroxetine at room temperature (20–25°C / 68–77°F), protect from moisture and heat, and keep it in the original packaging that shows the DIN and bilingual leaflet.
Keep medications out of reach of children and return unused or expired tablets to a pharmacy take‑back program for safe disposal.
Cold‑Chain Storage Where Applicable
Does paxil require refrigeration?
Paroxetine formulations do not require refrigeration or cold‑chain transport; store and transport per standard pharmaceutical practices with dry, temperature‑controlled rooms at community pharmacies and accurate electronic stock records for DINs and lots.
Guidelines For Proper Use
Advice From Canadian Pharmacists
What practical counselling points do pharmacists give about paxil?
Start at Health Canada monograph doses (for adults, commonly 20 mg/day), set expectations that benefit may take 2–6 weeks, warn about sexual side effects and the risk of discontinuation syndrome, and document DINs for provincial coverage.
Review the medication list for CYP2D6 interactions and advise slow tapering when stopping.
Provincial Health Authority Guidance
How do provincial rules affect prescribing and substitution?
Follow provincial formularies and mental health pathways; ODB, BC PharmaCare and RAMQ may specify substitution rules and preferred DINs.
Refer urgently to psychiatry if there is suicidal ideation or treatment resistance, and coordinate care for pregnancy planning with obstetrics and mental health services to balance relapse risk against foetal exposure concerns.
Delivery Across Canada (English)
| City | Region | Delivery Time |
|---|---|---|
| Toronto | Ontario | 5-7 days |
| Vancouver | British Columbia | 5-7 days |
| Montreal | Quebec | 5-7 days |
| Calgary | Alberta | 5-7 days |
| Edmonton | Alberta | 5-7 days |
| Ottawa | Ontario | 5-7 days |
| Winnipeg | Manitoba | 5-7 days |
| Halifax | Nova Scotia | 5-7 days |
| Victoria | British Columbia | 5-7 days |
| Saskatoon | Saskatchewan | 5-9 days |
| Regina | Saskatchewan | 5-9 days |
| St. John's | Newfoundland and Labrador | 5-9 days |
| Charlottetown | Prince Edward Island | 5-9 days |
| Kelowna | British Columbia | 5-9 days |
| Thunder Bay | Ontario | 5-9 days |
Final Notes For Patients
If starting paxil, expect to take your dose at about the same time each day to build steady blood levels.
If nausea or sleep disturbance occurs, take the tablet with food or try morning versus evening dosing based on side effects and prescriber advice.
Report any new severe agitation, suicidal thoughts, signs of hyponatraemia (confusion, weakness) or unusual bleeding right away to a prescriber or emergency services.
Generics from Apotex, Sandoz and Teva provide cost‑effective options and increase chances of provincial coverage when a listed DIN matches formulary preferences.
Pharmacy teams can help with tapering plans, check interactions (especially CYP2D6 concerns) and document DINs for reimbursement queries.